Stiff-person Syndrome Associated with Cerebellar Ataxia and High Glutamic Acid Decarboxylase Antibody Titer

41Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Glutamic acid decarboxylase (GAD) is the main target of humoral autoimmunity in patients with insulin-dependent diabetes mellitus (IDDM) and stiff-person syndrome. We reviewed the case of a 46-year-old woman who had cerebellar ataxia before getting stiff-person syndrome and IDDM with high anti-GAD autoantibody titers. This was a rare case in which there were both the clinical symptoms of stiff-person syndrome and cerebellar ataxia. In western blot analysis her serum reacted with 65-kDa proteins from rat cerebellum, cerebral cortex, and spinal cord. Autoantibodies to GAD may cause functional impairment of γ-aminobutyric acid (GABA) neurons in the spinal cord as well as in the cerebellum. © 2001, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Kono, S., Miyajima, H., Sugimoto, M., Suzuki, Y., Takahashi, Y., & Hishida, A. (2001). Stiff-person Syndrome Associated with Cerebellar Ataxia and High Glutamic Acid Decarboxylase Antibody Titer. Internal Medicine, 40(9), 968–971. https://doi.org/10.2169/internalmedicine.40.968

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free